Elafibranor Pharmacokinetic Parameters in Hepatic Impaired Patients

NCT03765671 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

30

Enrollment

INDUSTRY

Sponsor class

Conditions

Hepatic Impairment
Liver Disease
Pharmacokinetics

Interventions

DRUG: Elafibranor

Sponsor

Genfit

Collaborators

[object Object]
[object Object]